Xiaoke Di

797 total citations
25 papers, 627 citations indexed

About

Xiaoke Di is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xiaoke Di has authored 25 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Xiaoke Di's work include Esophageal Cancer Research and Treatment (9 papers), Gastric Cancer Management and Outcomes (6 papers) and RNA modifications and cancer (4 papers). Xiaoke Di is often cited by papers focused on Esophageal Cancer Research and Treatment (9 papers), Gastric Cancer Management and Outcomes (6 papers) and RNA modifications and cancer (4 papers). Xiaoke Di collaborates with scholars based in China, Japan and United States. Xiaoke Di's co-authors include Lia Tesfay, Lance D. Miller, Guodong Sui, Suzy V. Torti, Heather Hatcher, Mark C. Willingham, Ralph B. D’Agostino, Wei Wang, Timothy E. Kute and Frank M. Torti and has published in prestigious journals such as Oncogene, Science Translational Medicine and Journal of Ethnopharmacology.

In The Last Decade

Xiaoke Di

23 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoke Di China 12 252 185 156 127 123 25 627
Tim Kute United States 9 326 1.3× 192 1.0× 102 0.7× 114 0.9× 110 0.9× 9 752
Giorgia Federico Italy 10 220 0.9× 125 0.7× 186 1.2× 124 1.0× 111 0.9× 22 518
François Wilhelm United States 16 270 1.1× 220 1.2× 67 0.4× 90 0.7× 264 2.1× 64 796
Koji Miyagawa Japan 14 355 1.4× 66 0.4× 118 0.8× 130 1.0× 107 0.9× 20 670
Hideyuki Yasuno United States 10 135 0.5× 167 0.9× 112 0.7× 46 0.4× 163 1.3× 15 498
Zhimin Gu United States 12 459 1.8× 235 1.3× 62 0.4× 144 1.1× 169 1.4× 20 642
Maria Quiles del Rey United States 7 373 1.5× 70 0.4× 151 1.0× 341 2.7× 108 0.9× 8 625
Jacqueline Maier Germany 15 221 0.9× 278 1.5× 87 0.6× 96 0.8× 87 0.7× 27 718
Guillaume Kugener United States 11 439 1.7× 42 0.2× 199 1.3× 187 1.5× 149 1.2× 22 846
Jingping Ge China 10 368 1.5× 128 0.7× 102 0.7× 193 1.5× 67 0.5× 38 588

Countries citing papers authored by Xiaoke Di

Since Specialization
Citations

This map shows the geographic impact of Xiaoke Di's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoke Di with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoke Di more than expected).

Fields of papers citing papers by Xiaoke Di

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoke Di. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoke Di. The network helps show where Xiaoke Di may publish in the future.

Co-authorship network of co-authors of Xiaoke Di

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoke Di. A scholar is included among the top collaborators of Xiaoke Di based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoke Di. Xiaoke Di is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tian, Meng, Xiaoke Di, Jin Liu, et al.. (2025). Lactylation in radiosensitivity regulation: Mechanistic insights and recent advances. Seminars in Oncology. 52(5). 152394–152394.
2.
Zhang, Junfeng, Hui Chen, Minghui Zhao, et al.. (2024). Hypoxia inhibits ferritinophagy-mediated ferroptosis in esophageal squamous cell carcinoma via the USP2-NCOA4 axis. Oncogene. 43(26). 2000–2014. 9 indexed citations
3.
Liang, Liang, et al.. (2024). Comprehensive pan-cancer analysis of 33 human cancers reveals immunotherapeutic value of focal adhesion tyrosine kinase. Medicine. 103(12). e37362–e37362. 1 indexed citations
4.
Di, Xiaoke, et al.. (2023). Icariin improves learning and memory function in Aβ1-42-induced AD mice through regulation of the BDNF-TrκB signaling pathway. Journal of Ethnopharmacology. 318(Pt B). 117029–117029. 8 indexed citations
5.
Di, Xiaoke, et al.. (2023). Exploring the mechanism of Icariin in the treatment of depression through BDNF-TrkB pathway based on network pharmacology. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(1). 463–478. 9 indexed citations
7.
Di, Xiaoke, et al.. (2022). Identification of Immune and Hypoxia Risk Classifier to Estimate Immune Microenvironment and Prognosis in Cervical Cancer. Journal of Oncology. 2022. 1–20. 7 indexed citations
8.
Ge, Xiaolin, et al.. (2022). Diagnostic, Prognostic, and Recurrence Monitoring Value of Plasma CYFRA21-1 and NSE Levels in Patients With Esophageal Squamous Cell Carcinoma. Frontiers in Oncology. 11. 789312–789312. 12 indexed citations
9.
Gu, Junjie, Xiaoke Di, Xiaolin Ge, et al.. (2022). Irradiation induces DJ-1 secretion from esophageal squamous cell carcinoma cells to accelerate metastasis of bystander cells via a TGF-β1 positive feedback loop. Journal of Experimental & Clinical Cancer Research. 41(1). 259–259. 11 indexed citations
11.
Gao, Qing, Xiaolin Ge, Liu Ze-yuan, et al.. (2021). Chemoradiotherapy Is Superior to Radiotherapy Alone in Esophageal Cancer Patients Older Than 65 Years: A Propensity Score-Matched Analysis of the SEER Database. Frontiers in Oncology. 11. 736448–736448. 7 indexed citations
12.
Shi, Yujing, et al.. (2021). Circulating Tumor Cells in Esophageal Squamous Cell Carcinoma – Mini Review. Cancer Management and Research. Volume 13. 8355–8365. 12 indexed citations
13.
Chen, Hui, Xiaoke Di, Yixuan Zhang, et al.. (2020). MiR-450a-5p inhibits autophagy and enhances radiosensitivity by targeting dual-specificity phosphatase 10 in esophageal squamous cell carcinoma. Cancer Letters. 483. 114–126. 38 indexed citations
14.
Zhang, Zhao‐Yue, Liping Xu, Xiaoke Di, et al.. (2019). A retrospective study of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma. Annals of Palliative Medicine. 8(5). 708–716. 8 indexed citations
15.
Di, Xiaoke, et al.. (2018). Silencing human epidermal growth factor receptor‐3 radiosensitizes human luminal A breast cancer cells. Cancer Science. 109(12). 3774–3782. 12 indexed citations
16.
Qin, Qin, Jia Liu, Chi Zhang, et al.. (2018). Does timing of esophagectomy following neoadjuvant chemoradiation affect outcomes? A meta-analysis. International Journal of Surgery. 59. 11–18. 41 indexed citations
17.
Song, Hongmei, Hongcheng Zhu, Xiaoke Di, et al.. (2017). Nutlin-3, an Antagonist of MDM2, Enhances the Radiosensitivity of Esophageal Squamous Cancer with Wild-Type p53. Pathology & Oncology Research. 24(1). 75–81. 18 indexed citations
18.
Zhu, Hongcheng, Hongmei Song, Xi Yang, et al.. (2017). eEF2K promotes progression and radioresistance of esophageal squamous cell carcinoma. Radiotherapy and Oncology. 124(3). 439–447. 35 indexed citations
19.
Yang, Jie, Qiang Lu, Zhijian Han, et al.. (2012). Prostate cancer risk and aggressiveness associated with the CYP1B1 4326C/G (Leu432Val) polymorphism: a meta-analysis of 2788 cases and 2968 controls. Asian Journal of Andrology. 14(4). 560–565. 14 indexed citations
20.
Miller, Lance D., Wei Wang, Ralph B. D’Agostino, et al.. (2010). Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis. Science Translational Medicine. 2(43). 43ra56–43ra56. 324 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026